Logo image of AMWL

AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

NYSE:AMWL - New York Stock Exchange, Inc. - US03044L2043 - Common Stock - Currency: USD

7.04  +0.03 (+0.43%)

Fundamental Rating

3

AMWL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for AMWL as it has an excellent financial health rating, but there are worries on the profitability. AMWL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMWL had negative earnings in the past year.
In the past year AMWL has reported a negative cash flow from operations.
In the past 5 years AMWL always reported negative net income.
AMWL had a negative operating cash flow in each of the past 5 years.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

AMWL has a Return On Assets of -36.89%. This is in the lower half of the industry: AMWL underperforms 68.57% of its industry peers.
With a Return On Equity value of -52.64%, AMWL is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -36.89%
ROE -52.64%
ROIC N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

The Gross Margin of AMWL (44.53%) is worse than 68.57% of its industry peers.
AMWL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMWL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMWL has less shares outstanding
Compared to 5 years ago, AMWL has less shares outstanding
There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

AMWL has an Altman-Z score of -6.16. This is a bad value and indicates that AMWL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -6.16, AMWL is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.16
ROIC/WACCN/A
WACC10.03%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.92 indicates that AMWL has no problem at all paying its short term obligations.
The Current ratio of AMWL (2.92) is better than 68.57% of its industry peers.
A Quick Ratio of 2.89 indicates that AMWL has no problem at all paying its short term obligations.
AMWL has a better Quick ratio (2.89) than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.89
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

AMWL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.77%, which is quite impressive.
AMWL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.79%.
Measured over the past years, AMWL shows a quite strong growth in Revenue. The Revenue has been growing by 11.30% on average per year.
EPS 1Y (TTM)55.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.4%
Revenue 1Y (TTM)2.79%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.28%

3.2 Future

The Earnings Per Share is expected to grow by 12.97% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.90% on average over the next years.
EPS Next Y52.89%
EPS Next 2Y28.06%
EPS Next 3Y20.76%
EPS Next 5Y12.97%
Revenue Next Year2.49%
Revenue Next 2Y4.75%
Revenue Next 3Y8.43%
Revenue Next 5Y5.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

AMWL's earnings are expected to grow with 20.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.06%
EPS Next 3Y20.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMWL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (8/4/2025, 8:04:00 PM)

7.04

+0.03 (+0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners43.19%
Inst Owner Change0%
Ins Owners2.69%
Ins Owner Change1.42%
Market Cap111.30M
Analysts71.43
Price Target10.49 (49.01%)
Short Float %1.42%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.2%
Min EPS beat(2)7.21%
Max EPS beat(2)31.2%
EPS beat(4)4
Avg EPS beat(4)18.18%
Min EPS beat(4)7.21%
Max EPS beat(4)31.2%
EPS beat(8)5
Avg EPS beat(8)-13.55%
EPS beat(12)8
Avg EPS beat(12)-8.18%
EPS beat(16)11
Avg EPS beat(16)-2.1%
Revenue beat(2)2
Avg Revenue beat(2)6.75%
Min Revenue beat(2)4.58%
Max Revenue beat(2)8.93%
Revenue beat(4)2
Avg Revenue beat(4)2%
Min Revenue beat(4)-5.41%
Max Revenue beat(4)8.93%
Revenue beat(8)2
Avg Revenue beat(8)-0.98%
Revenue beat(12)2
Avg Revenue beat(12)-1.1%
Revenue beat(16)3
Avg Revenue beat(16)-1.46%
PT rev (1m)2.86%
PT rev (3m)-5.42%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)16.05%
EPS NY rev (1m)2.5%
EPS NY rev (3m)23.06%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)-3.99%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-10.88
EYN/A
EPS(NY)-5.04
Fwd EYN/A
FCF(TTM)-6.64
FCFYN/A
OCF(TTM)-5.86
OCFYN/A
SpS16.55
BVpS18.59
TBVpS12.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.89%
ROE -52.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.53%
FCFM N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.92%
Cap/Sales 4.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.89
Altman-Z -6.16
F-Score5
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)44.83%
Cap/Depr(5y)34.13%
Cap/Sales(3y)5.21%
Cap/Sales(5y)3.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.4%
EPS Next Y52.89%
EPS Next 2Y28.06%
EPS Next 3Y20.76%
EPS Next 5Y12.97%
Revenue 1Y (TTM)2.79%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.28%
Revenue Next Year2.49%
Revenue Next 2Y4.75%
Revenue Next 3Y8.43%
Revenue Next 5Y5.9%
EBIT growth 1Y38.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.48%
EBIT Next 3Y25.23%
EBIT Next 5Y16.09%
FCF growth 1Y40.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.81%
OCF growth 3YN/A
OCF growth 5YN/A